Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will estimate the annual cost of Meningitis B to (a) the NHS and (b) social care.
The impact of meningococcal B disease to the National Health Service and social care were included as part of the estimated cost effectiveness analysis by Christensen et al. in their study published in the BMJ on 10 October 2014, ‘Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study’ (BMJ 2014; 349: g5725).